Zhejiang Shengda Bio-Pharm Co Ltd
SSE:603079
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zhejiang Shengda Bio-Pharm Co Ltd
SSE:603079
|
CN |
|
R
|
Rizal Commercial Banking Corp
XPHS:RCB
|
PH |
|
S
|
Shaanxi Meibang Pharmaceutical Group Co Ltd
SSE:605033
|
CN |
|
Mullen Automotive Inc
NASDAQ:MULN
|
US |
|
Saregama India Ltd
BSE:532163
|
IN |
|
YouYou Foods Co Ltd
SSE:603697
|
CN |
|
MPLX LP
NYSE:MPLX
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Zhejiang Shengda Bio-Pharm Co Ltd's stock price target?
Not Available
Zhejiang Shengda Bio-Pharm Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Zhejiang Shengda Bio-Pharm Co Ltd's Revenue forecast?
Projected CAGR
-6%
For the last 9 years the compound annual growth rate for Zhejiang Shengda Bio-Pharm Co Ltd's revenue is 5%. The projected CAGR for the next 7 years is -6%.
What is Zhejiang Shengda Bio-Pharm Co Ltd's Net Income forecast?
Projected CAGR
14%
For the last 9 years the compound annual growth rate for Zhejiang Shengda Bio-Pharm Co Ltd's net income is -11%. The projected CAGR for the next 7 years is 14%.
